Implementation of the KDIGO guideline on lipid management requires a substantial increase in statin prescription rates

Kidney International
Markus P SchneiderKai-Uwe Eckardt

Abstract

The KDIGO guideline on lipid management in adult patients with chronic kidney disease (CKD) reflects a paradigm shift as proposals for statin use are based on cardiovascular risk rather than cholesterol levels. Statin use is now universally recommended in CKD patients 50 years and older, assuming a 10-year risk of coronary heart disease (CHD) of over 10%. Specific comorbidities or formal risk calculation are required for younger patients. It is unknown to which extent these new guidelines differ from previous practice. Here we analyzed statin use in the German Chronic Kidney Disease study of 5217 adult patients with moderately severe CKD under nephrological care enrolled shortly before publication of the new guideline. Accordingly, 407 patients younger than 50 years would be eligible for statins compared with the 277 patients treated so far, and all 4224 patients 50 years and older would be eligible compared with the 2196 already treated. Overall, guideline implementation would almost double statin prescription from 47 to 88%. Among patients 50 years and older currently not on a statin, an estimated 10-year CHD and atherosclerotic event risks over 10% were present in 68% and 82%, respectively. Thus, implementation of the new li...Continue Reading

References

Jan 1, 1991·Circulation·K M AndersonW B Kannel
Sep 29, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·T QuaschningC Wanner
Jul 22, 2005·The New England Journal of Medicine·Christoph WannerUNKNOWN German Diabetes and Dialysis Study Investigators
Jul 17, 2007·Journal of the American College of Cardiology·Daniel E WeinerMark J Sarnak
Apr 26, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Laura Cortés-SanabriaHéctor R Martínez-Ramírez
May 7, 2008·Annals of Internal Medicine·Paul P GlasziouUNKNOWN LIPID Study Investigators
Apr 1, 2009·The New England Journal of Medicine·Bengt C FellströmUNKNOWN AURORA Study Group
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Jun 17, 2009·Heart·Osamu TakahashiTsuguya Fukui
Aug 25, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Kai-Uwe EckardtStephanie Titze
Nov 5, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Mona RazavianAlan Cass
Jan 19, 2012·Circulation. Cardiovascular Quality and Outcomes·Rodney A Hayward, Harlan M Krumholz
Aug 23, 2012·Annals of Internal Medicine·Ashish UpadhyayEthan M Balk
Mar 19, 2013·Journal of the American College of Cardiology·Kevin F EricksonJeremy D Goldhaber-Fiebert
May 21, 2013·Journal of the American Society of Nephrology : JASN·Marcello TonelliUNKNOWN Alberta Kidney Disease Network
Apr 1, 2014·JAMA : the Journal of the American Medical Association·Paul MuntnerMonika M Safford
Oct 2, 2014·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Stephanie TitzeUNKNOWN GCKD study investigators
Nov 15, 2014·Journal of the American Society of Nephrology : JASN·Lisandro D ColantonioPaul Muntner
Jan 1, 2013·Kidney International Supplements

❮ Previous
Next ❯

Citations

May 18, 2016·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Wisit CheungpasitpornStephen B Erickson
Nov 2, 2016·Journal of the American Society of Nephrology : JASN·Sophie J Bernelot MoensErik S G Stroes
Oct 27, 2018·Nature Reviews. Nephrology·Charles J FerroCarmine Zoccali
Apr 6, 2017·Clinical Journal of the American Society of Nephrology : CJASN·Liam MannsBrenda Hemmelgarn
Jul 3, 2020·Clinical Journal of the American Society of Nephrology : CJASN·Solène M LavilleUNKNOWN Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Group
Jan 7, 2017·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Sophie LiabeufZiad A Massy
Mar 2, 2021·Deutsche medizinische Wochenschrift·Christoph WannerKai Lopau

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.